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Breast cancer is the most frequent malignancy in women accounting for approximately 32% of all cancers, with a lifetime risk of 1
in 10. It causes considerable morbidity and mortality. Recently, the survival rate has dramatically increased due to early detection
of the disease and improvement in the treatment measures. However, more than 30% of the patients develop metastatic diseases
following surgical treatment, radiotherapy, hormonal therapy, or chemotherapy. Distant spread is usually found in bones, lungs,
liver, brain and skin. Rarely, it spreads to bowel, spleen, gallbladder, pancreas, urinary bladder, and eyes. Breast cancer is the
second commonest primary tumour responsible for gastrointestinal metastases after malignant melanoma. We report a case of
a Caucasian female who developed an intestinal obstruction secondary to metastatic deposits to the small bowel and later to the
rectumfrombreastlobularcarcinoma2yearsaftermastectomy,axillaryclearance, radiotherapy,hormonaltherapy,andtransverse
rectus abdominis myocutaneous (TRAM) ﬂap for reconstruction.
1. Case Presentation
In September 2008, a 70 years old female was diagnosed with
a lobular carcinoma after a core biopsy of a mass in her
left breast. A month later, she underwent skin sparing mas-
tectomy and axillary clearance, the histological examination
conﬁrmed a grade 2 invasive lobular carcinoma, estrogen
receptor positive (ER+), progesterone receptor negative
(PR−), and human epidermal growth factor receptor 2 neg-
ative (Her2−).There was no vascular space invasion, no in
situ component and the axillary tissue included eight lymph
nodes,threeofthosecontainedmetastaticlobularcarcinoma
with extracapsular spread. A CT scan to chest and abdomen
and a bone scan showed no evidence of any metastatic dis-
ease. Subsequently, she had radiotherapy and was started on
adjuvant hormonal treatment, but because of her past med-
ical history which includes previous nephrectomy for pelvic
ureteric junction (PUJ) obstruction 10 year ago, arthritis and
essential hypertension, chemotherapy was not considered. In
early 2010, the patient was referred to the Department of
Plastic Surgery for breast reconstruction, as she continued
to show no clinical evidence of any recurrence, she un-
derwent reconstruction with a pedicle transverse rectus
abdominis myocutaneous (TRAM) ﬂap.
One month later she had multiple episodes of abdominal
pain and constipation which needed hospital admission.
AC Ts c a ns h o w e de v i d e n c eo fs m a l lb o w e lo b s t r u c t i o n
(Figure 1); a laparotomy and resection of a thickened and
narrowed terminal ileum were carried out followed by bowel
anastomosis. The histological analysis conﬁrmed the pres-
ence of widely inﬁltrated small bowel by well-diﬀerentiated
epithelial cells, some of which contained intracytoplasmic
lumina and formed a single ﬁle pattern of inﬁltration
(Figure 4). The appearances were those of metastatic lobular
carcinoma of breast, which was ER positive and E-cadherin
&H e r2n e g a t i v e( Figure 5), invaded the mucosa, the
mesentery, and appeared to extend beyond the mesenteric
margins of excision. A subsequent chest/abdomen CT scan
andabonescanshowednosignsofothermetastasis.Contra-
lateral carcinoma was excluded by clinical examination and
mammogram. The patient was started on a new hormone
therapy.2 International Journal of Breast Cancer
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Figure 1: CT scan shows small bowel dilatation, no other speciﬁc
features.
Figure 2: CT scan reveals left hydronephrosis secondary to com-
pression on lower ureter by a rectal mass, previous right nephrecto-
my.
Unfortunately, 3 months later, the patient had new epi-
sodes of diarrhoea with fresh blood; sigmoidoscopy showed
anarrowedlumenandﬁrmswollenmucosaattheupperrec-
tum (Figure 3); biopsies revealed the presence of metastatic
lobular carcinoma of breast, the tumour foci stained pos-
itive with cytokeratin 7 (CK7), pancytokeratins, and ER.
Staging CT scan identiﬁed left hydronephrosis caused by
compression on the ureter from the metastasis in the rectum
(Figure 2). No extraintestinal spread reported; the patient
had a ureteric stent put in, and she was subsequently started
on palliative therapy.
2. Discussion
The most common metastatic sites from breast cancer are
well known, the lungs, bones, liver, and brain whereas the
involvement of the gastrointestinal tract remains very unu-
sual. Borst published a large series that analyzed more than
2500 cases of breast cancer with metastatic disease over a
period of 18 years; he found that only 17 patients (less
Figure 3: View at sigmoidoscopy showing narrowed lumen, which
was felt to be due to a ﬁrm and swollen mucosa by the endoscopist.
Figure 4: Small bowel mucosa inﬁltrated by cords of metastatic
lobular adenocarcinoma cells. (Haematoxylin and eosin, original
magniﬁcation ×400.)
than 1%) had metastasis to the GI tract [1]. Metastasis to
the stomach and small bowel have been more frequently
reported than colonic and rectal ones. However, in a retro-
spective study, McLemore reported 23 cases of GI metastasis,
he found that the disease is more frequent in the mid- and
hindgut than in the foregut (oesophagus 8%, stomach 28%,
small intestine 19% and colon-rectum 45%) [2]. Despite
the greater prevalence of inﬁltrative ductal breast carcinoma
among women (90%), lobular breast cancer has a speciﬁc
metastatic pattern and more frequently metastasizes to the
GI tract and the retroperitoneal tissue than ductal cancer [3].
McLemore also reported that inﬁltrating lobular carcinoma
represented 64% of the gastrointestinal metastasis. It has also
been reported that even in patients with a mixed ductal and
lobular primary breast carcinoma, the lobular type is the
most likely to cause metastatic disease [4].
The presenting symptoms and signs of metastatic disease
to the GI tract are usually nonspeciﬁc, often mimicking
other gastrointestinal disorders; this patient presented with
multipleepisodesofintermittedabdominalpainandrestrainInternational Journal of Breast Cancer 3
Figure 5:Thesameslidestainedwithantibodytoestrogenreceptor.
The malignant cells stain brown (ER clone 6F11, original magniﬁ-
cation ×400).
ofstool;theinitialthoughtwasthatshemighthadadhesional
obstruction or incarcerated incisional hernia as a compli-
cation of the pedicel TRAM, but clinically there was no
evidence of hernias. Diagnosis of GI metastasis from breast
cancer could be diﬃcult prior to surgical intervention; the
ﬁndings of diagnostic imaging are frequently not speciﬁc for
GImetastasis;thepicturecanalsomimicCrohn’sdisease[5].
GI endoscopy with deep biopsy is widely used for accurate
diagnosis depending on the patient status [6].
Santini et al. reported an interesting case where an in-
crease in cancer antigen CA 19.9 was used to diagnose me-
tastatic lobular breast cancer to ileocecal valve in a symp-
tomatic patient [7]. Establishing the histological origin could
be challenging, metastases of lobular carcinomas have a
typicalfashionofspreadwithintramuralinﬁltrationgrowing
within the serosal, muscular, and submucosal layers with
small cells in cords throughout the tissue [8].Compared to
primary adenocarcinoma of bowel, the metastatic lobular
carcinoma is usually positive for CK 7, ER, PR and GCDFP
15 and negative for vimentin, while CK 20 and CEA are
almost invariably present in primary gastrointestinal tum-
ours and absent in breast carcinomas [9, 10]. In this case,
the metastatic disease was positive for ER, and negative for
PR and HER2, which matched the immunohistochemical
ﬁndingsoftheprimarybreastcancer;thisﬁnding,alongwith
the unique histological pattern of the disease, favoured the
diagnosis of metastatic lobular breast carcinoma.
The management of metastatic breast cancer to GI tract
is still controversial. It may involve systemic hormonal or
chemotherapy either alone or combined with surgery since
patients usually present with the involvement of multiple
organs, despite not detecting extensive disease in preopera-
tive investigation [11]. Patients with intestinal obstruction,
perforation, or bleeding require palliative surgical interven-
tion but that does not extend the patient survival. Interest-
ingly,Tangetal.reported2caseswhentheintestinalobstruc-
tion due to metastatic lobular carcinoma was settled with
a parenteral endocrine hormonal agent (fulvestrant) [12].
Long-term survival rate has been reported after resection
of an isolated GI metastatic lesion whilst surgery combined
with chemotherapy may result in long-term remission [7,
13]. Bowel surgery in postmastectomy patients who have
undergone Transverse Rectus Abdominis Myocutaneous
(TRAM) ﬂap would require careful preoperative planning of
surgical incision, and the need for stoma cannot be ruled out
[14, 15].
In summary, metastasis to GI tract from breast cancer
is a rare condition and not easy to diagnose. This diagnosis
should be suspected when the patient has a history of breast
cancer especially of lobular type. Not surprisingly, in most
cases, GI metastasis is part of widespread disease, and early
diagnosis may help towards the improvement of the out-
come. This case also emphasizes the importance of patients’
suitability for breast reconstruction, despite the patient her-
self making the decision to go for TRAM ﬂap as a means of
delayed reconstruction after knowing the pros and cons, less
invasive procedures and techniquesshould be made available
and must be considered in patients with a kind of cancer that
carries high risks of recurrence.
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